Pacira BioSciences (PCRX) Goodwill (2012 - 2026)

Pacira BioSciences' Goodwill history runs 15 years deep, the most recent figure standing at $19.8 million for Q1 2026.

• On a quarterly basis, Goodwill fell 8.12% year-over-year to $19.8 million in Q1 2026; TTM through Mar 2026 was $19.8 million, a 8.12% decrease from a year earlier, with the FY2025 full-year figure at $20.2 million, changed N/A from the prior year.
• Goodwill retreated to $19.8 million in Q1 2026 per PCRX's latest filing, from $20.2 million in the prior quarter.
• Across five years, Goodwill topped out at $163.2 million in Q1 2023 and bottomed at $19.8 million in Q1 2026.
• The 5-year median for Goodwill is $157.4 million (2022), against an average of $112.9 million.
• Across the five-year window, Goodwill soared 58.12% in 2022 and tumbled 87.56% in 2025, its largest moves.
• Year by year, Goodwill stood at $163.2 million in 2022, then rose by 0.03% to $163.2 million in 2023, then declined by 0.03% to $163.2 million in 2024, then slumped by 87.62% to $20.2 million in 2025, then slipped by 2.11% to $19.8 million in 2026.
• Per Business Quant, the three latest PCRX Goodwill figures stand at $19.8 million (Q1 2026), $20.2 million (Q4 2025), and $20.3 million (Q3 2025).